Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C11orf68 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | HFM1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | MYO15B | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | NME6 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
mRNA | TRIM24 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | OPRD1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | C2orf15 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | CENPV | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | KCNA2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | PIGA | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |